Literature DB >> 6818999

[Interaction of chloroquine with ferriprotophorphyrin IX. Nuclear magnetic resonance study].

S Moreau, B Perly, J Biguet.   

Abstract

Chloroquine is still the antimalarial drug which is the most utilized. Nevertheless the molecular mode of action of this drug is not very well understood. When mouse erythrocytes injected with Plasmodium berghei are exposed to chloroquine, the first biochemical event is rapid accumulation of the drug. This process is energy dependent, saturable and competitively inhibited by drugs of the same therapeutic class (Quinine, Amodiaquine, Mefloquine). Receptors for chloroquine have been proposed for the process of accumulation. The nature of the chloroquine receptor is presently the subject of debates. The latest hypothesis proposed by Chou and coll. [12], is that ferriprotoporphyrin IX, formed by the degradation of hemoglobin by the parasite, binds to chloroquine with a dissociation constant of 3.5.10(-9) M. We studied here the molecular interactions between these two species by Proton Nuclear Magnetic Resonance in order to elucidate the nature and the geometry of were undertaken. The perturbations of the NMR spectra of chloroquine (10(-2) M) induced by addition of hematin or hemin were measured. Two types of measures were undertaken. The first study carried out in organic solvent (DMSO) has shown that the interaction occurred between the acidic functions of hemin and the side-chain nitrogen of chloroquine. The iron atom was not implicated in this process. The second study carried out in aqueous medium (phosphate buffer; 0.1 M; pH = 7) allowed us to demonstrate that chloroquine is able to intercalate into a polymer of hematin. The quinoleic nucleus of chloroquine was intercalated between two dimers of hematin as shown by the broadening of the signal of the quinoleic protons due to very large increase in the correlation time. Finally it was shown that chloroquine is associated as a dimer in aqueous medium by hydrophobic interactions. The association constant is 5.5 M-1.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6818999     DOI: 10.1016/s0300-9084(82)80382-9

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  7 in total

1.  Computational studies of new potential antimalarial compounds--stereoelectronic complementarity with the receptor.

Authors:  César Portela; Carlos M M Afonso; Madalena M M Pinto; Maria João Ramos
Journal:  J Comput Aided Mol Des       Date:  2003-09       Impact factor: 3.686

2.  Speciation and structure of ferriprotoporphyrin IX in aqueous solution: spectroscopic and diffusion measurements demonstrate dimerization, but not mu-oxo dimer formation.

Authors:  Katherine A de Villiers; Catherine H Kaschula; Timothy J Egan; Helder M Marques
Journal:  J Biol Inorg Chem       Date:  2006-09-14       Impact factor: 3.358

3.  Inhibition of the peroxidative degradation of haem as the basis of action of chloroquine and other quinoline antimalarials.

Authors:  P Loria; S Miller; M Foley; L Tilley
Journal:  Biochem J       Date:  1999-04-15       Impact factor: 3.857

4.  The Alimentary Tract of African Bony-Tongue, Heterotis niloticus (Cuvier, 1829): Morphology Study.

Authors:  Maria Cristina Guerrera; Marialuisa Aragona; Marilena Briglia; Caterina Porcino; Kamel Mhalhel; Marzio Cometa; Francesco Abbate; Giuseppe Montalbano; Rosaria Laurà; Maria Levanti; Germana Germanà; Giacomo Zaccone; Krystyna Zuwala; Michal Kuciel; Antonino Germanà
Journal:  Animals (Basel)       Date:  2022-06-17       Impact factor: 3.231

5.  In vitro antimalarial activity of metalloporphyrins against Plasmodium falciparum.

Authors:  Khurshida Begum; Hye-Sook Kim; Veena Kumar; Igor Stojiljkovic; Yusuke Wataya
Journal:  Parasitol Res       Date:  2003-03-12       Impact factor: 2.289

Review 6.  Antimalarial drugs. An update.

Authors:  D C Warhurst
Journal:  Drugs       Date:  1987-01       Impact factor: 9.546

7.  Implications of Glutathione Levels in the Plasmodium berghei Response to Chloroquine and Artemisinin.

Authors:  Joel Vega-Rodríguez; Rebecca Pastrana-Mena; Keila N Crespo-Lladó; José G Ortiz; Iván Ferrer-Rodríguez; Adelfa E Serrano
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.